Importance Estimating the current likelihood of transitioning from a clinical high risk for
psychosis (CHR-P) to psychosis holds paramount importance for preventive care and …

Meta-analytic evidence indicates that baseline exposure to antipsychotics (AP) in individuals
at clinical high-risk for psychosis (CHR-P) is associated with an even higher risk of transition …

The first rate-limiting step to successfully translate prevention of psychosis in to clinical
practice is to establish specialised Clinical High Risk for Psychosis (CHR-P) services. This …

Aquatic ecosystems are primary repositories for microplastics (MPs), which pose significant
risks to aquatic organisms. This study addresses the gap in understanding the effects of MPs …

Abstract Objective Duration of Untreated Psychosis (DUP) remains unacceptably long and
limits effectiveness of care. To determine whether an early detection campaign (“Mindmap”) …

Prediction and prevention of negative clinical and functional outcomes represent the two
primary objectives of research conducted within the clinical high-risk for psychosis (CHR-P) …

BackgroundEmerging meta-analytical evidence indicates that baseline exposure to
antipsychotics and to antidepressants in individuals at clinical high-risk for psychosis (CHR …

BackgroundThe clinical high-risk (CHR) for psychosis paradigm is changing psychiatric
practice. However, a widespread confounder, ie baseline exposure to antipsychotics (AP) in …

Background Most services for individuals at Clinical High Risk for Psychosis (CHR-P)
provide short-term clinical care. This study determines the real-world and long-term clinical …

Background The efficacy of pharmacological and nutritional interventions in individuals at
clinical high risk for psychosis (CHR-P) remains elusive. This study aims to investigate the …